The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Abiologics Appoints Maria Chiara Magnone, Ph.D. As Chief Scientific Officer
PRIVATESep 25, 2024•over 1 year ago
Position
Chief Scientific Officer
Company
Abiologics
Maria-Chiara Magnone
CambridgeBiotechnologyArtificial Intelligence
Description
Abiologics announced the appointment of Maria-Chiara Magnone, Ph.D., as Chief Scientific Officer. Magnone brings two decades of experience in all stages of drug development across a wide range of therapeutic areas.
Company Information
Company
Abiologics
Location
Cambridge, Massachusetts, United States
About
Abiologics is pioneering a new class of supranatural and programmable biologics, called Synteins™. The Abiologics platform leverages cutting-edge generative artificial intelligence and high-throughput chemical protein synthesis to computationally-design Synteins de novo using a broad set of artificial building blocks, far beyond the 20 naturally occurring amino acids that form the basis of today’s biologic medicines.
CambridgeBiotechnologyArtificial Intelligence